Latest News

CCL Industries Announces 2026 Annual and Special Shareholders' Meeting Results

Intrusion Inc. to Present at the Sidoti Micro Cap Investor Conference

First Canadian Graphite to Attend the Mining Investment Event in Quebec City

UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC

INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform

CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results

MANTECH Names Sarah Carter as Chief Growth Officer

Perma-Fix Announces Pricing of $20.0 Million Public Offering of Common Stock